IRLAB Therapeutics AB (publ) (STO:IRLAB.A)

IRLAB Therapeutics AB Statistics

Total Valuation

STO:IRLAB.A has a market cap or net worth of SEK 266.28 million. The enterprise value is 288.39 million.

Market Cap	266.28M
Enterprise Value	288.39M

Important Dates

The last earnings date was Wednesday, August 27, 2025.

Earnings Date	Aug 27, 2025
Ex-Dividend Date	n/a

Share Statistics

STO:IRLAB.A has 84.94 million shares outstanding. The number of shares has increased by 0.00% in one year.

Current Share Class	84.86M
Shares Outstanding	84.94M
Shares Change (YoY)	+0.00%
Shares Change (QoQ)	-0.00%
Owned by Insiders (%)	13.41%
Owned by Institutions (%)	20.05%
Float	66.48M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.52
PB Ratio	-9.62
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-2.79
EV / Sales	3.81
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.51

Financial Position

The company has a current ratio of 0.44

Current Ratio	0.44
Quick Ratio	0.44
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-1.18
Interest Coverage	-4.58

Financial Efficiency

Return on equity (ROE) is -492.02% and return on invested capital (ROIC) is -61.13%.

Return on Equity (ROE)	-492.02%
Return on Assets (ROA)	-31.94%
Return on Invested Capital (ROIC)	-61.13%
Return on Capital Employed (ROCE)	326.80%
Revenue Per Employee	2.52M
Profits Per Employee	-3.44M
Employee Count	31
Asset Turnover	0.46
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -78.57% in the last 52 weeks. The beta is 0.44, so STO:IRLAB.A's price volatility has been lower than the market average.

Beta (5Y)	0.44
52-Week Price Change	-78.57%
50-Day Moving Average	3.48
200-Day Moving Average	8.50
Relative Strength Index (RSI)	40.83
Average Volume (20 Days)	170,223

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, STO:IRLAB.A had revenue of SEK 75.74 million and -103.34 million in losses. Loss per share was -1.99.

Revenue	75.74M
Gross Profit	-48.71M
Operating Income	-84.60M
Pretax Income	-103.34M
Net Income	-103.34M
EBITDA	-83.77M
EBIT	-84.60M
Loss Per Share	-1.99

Balance Sheet

The company has 53.64 million in cash and 75.76 million in debt, giving a net cash position of -22.11 million or -0.26 per share.

Cash & Cash Equivalents	53.64M
Total Debt	75.76M
Net Cash	-22.11M
Net Cash Per Share	-0.26
Equity (Book Value)	-27.68M
Book Value Per Share	-0.53
Working Capital	-80.31M

Cash Flow

In the last 12 months, operating cash flow was -63.78 million and capital expenditures -199,000, giving a free cash flow of -63.98 million.

Operating Cash Flow	-63.78M
Capital Expenditures	-199,000
Free Cash Flow	-63.98M
FCF Per Share	-0.75

Margins

Gross margin is -64.31%, with operating and profit margins of -111.69% and -136.43%.

Gross Margin	-64.31%
Operating Margin	-111.69%
Pretax Margin	-136.43%
Profit Margin	-136.43%
EBITDA Margin	-110.60%
EBIT Margin	-111.69%
FCF Margin	n/a

Dividends & Yields

STO:IRLAB.A does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.00%
Shareholder Yield	n/a
Earnings Yield	-38.81%
FCF Yield	-24.03%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 28, 2019. It was a forward split with a ratio of 5.

Last Split Date	May 28, 2019
Split Type	Forward
Split Ratio	5

Scores

STO:IRLAB.A has an Altman Z-Score of -8.81 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-8.81
Piotroski F-Score	3